Dechra Pharmaceuticals PLC (LSE:DPH) Annual Report 2021



The latest annual report of Dechra Pharmaceuticals PLC (DPH) was published on 30 Jun 2021. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - DPH Annual Results

Amounts in GBP

Total Revenue
608M
Gross Profit
345.9M
EBIT
87M
Net Tangible Assets
-77.3M
Net Income
55.5M
Capital Expenditures
-18.9M

DPH Income Statement 2021 Annual Report

As per the latest Income Statement of DPH, the Net revenue increased by £92.90M (18%) compared to the previous period. The operating income in 2021 increased by £28.30M (48%). The net income as per the annual report was 55.5M which increased by £21.60M (64%) compared to previous year.

Income Statement Report (2021/2020)

20212020
Total Revenue608M515.1M
Gross Profit345.9M291.6M
Operating Income87M58.7M
Income Before Tax74M40.9M
Net Income55.5M33.9M

Balance Sheet - DPH 2021 Annual Report

Read further: DPH Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Dechra Pharmaceuticals PLC showed the company reduced the cash on balance sheet by £-109.00M (-48%). The Net tangible assets of DPH on the balance sheet were at -77.3M which is £-28.70M (-59%) less than previous annual report. The total stockholder equity also decreased by £-4.60M (-1%) compared to previous reporting period.

Balance Sheet Statement Report (2021/2020)

20212020
Cash118.4M227.4M
Total Assets1.21B 1.24B
Long Term Debt302.7M338.6M
Total Liabilities581.2M 600.1M
Total Shareholder Equity632.9M637.5M
Net Tangible Assets-77.3M-48.6M

Cash Flow Statement - DPH 2021 Annual Report

The 2021 annual cash flow statement of Dechra Pharmaceuticals PLC showed that the net income increased by £21.60M (64%) compared to previous reporting period. Also the capital expenditure of DPH decreased by £-11.10M (-142%).

As of 2021, the total cash from investing activities was -136.1M and total cash from financing activities was -55.1M.

Cash Flow Statement Report (2021/2020)

20212020
Net Income55.5M33.9M
Capital Expenditures-18.9M-7.8M
Dividends Paid-37.9M-33.3M
Total Cash From From Investing Activities-136.1M-81.5M
Total Cash From From Financing Activities-55.1M118.9M

Dechra Pharmaceuticals PLC Annual Report History

Income Statement

Income Statement history of Dechra Pharmaceuticals PLC (LSE:DPH)

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Total Revenue608M515.1M481.8M407.1M
Cost Of Revenue262.1M223.5M203.6M179.6M
Gross Profit345.9M291.6M278.2M227.5M
Research Development36.8M34.1M31.9M26.3M
Selling General Administrative222.1M198.8M195.7M156.1M
Non Recurring----
Other Operating Expenses----
Total Operating Expenses521M456.4M431.2M362M
Operating Income87M58.7M50.6M45.1M
Total Other Income Expense Net-13M-17.8M-22.8M-16.2M
Ebit87M58.7M50.6M45.1M
Interest Expense-8.8M-11.5M-10.5M-6.8M
Income Before Tax74M40.9M27.8M28.9M
Income Tax Expense18.5M7M-3.1M-7.2M
Minority Interest----
Net Income From Continuing Ops55.5M33.9M30.9M36.1M
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Charges----
Other Items----
Net Income55.5M33.9M30.9M36.1M
Net Income Applicable To Common Shares55.5M33.9M30.9M36.1M

Balance Sheet Statement

Balance Sheet Statement history of Dechra Pharmaceuticals PLC (LSE:DPH)

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Cash118.4M227.4M80.3M79.7M
Net Receivables119.2M97.3M103.8M79M
Inventory149.5M120.8M103.5M86.6M
Total Current Assets392.2M448.9M291.5M247.9M
Long Term Investments17.1M17.4M10.1M10.5M
Property Plant Equipment87M76.4M58.4M45.3M
Good Will236.1M253.8M245.7M229.3M
Intangible Assets474.1M432.3M429.4M474.4M
Other Assets7.6M8.8M6.4M9.9M
Deferred Long Term Asset Charges2M2.7M900k3.8M
Total Assets1.21B1.24B1.04B1.02B
Accounts Payable35.2M34.6M31.9M33M
Other Current Liab43.1M37.6M23.3M27M
Long Term Debt302.7M338.6M306.9M289.9M
Other Liab109.9M112.4M107.4M130.8M
Deferred Long Term Liab5.6M6.1M5.5M6.1M
Total Current Liabilities155.8M137.3M118.1M91.6M
Total Liab581.2M600.1M532.4M512.3M
Common Stock1.1M1.1M1M1M
Retained Earnings147.7M126.4M124.2M125.5M
Treasury Stock72.5M100.7M106M101.8M
Capital Surplus411.6M409.3M277.9M276.7M
Other Stockholder Equity72.5M100.7M106M102.2M
Total Stockholder Equity632.9M637.5M509.1M505M
Net Tangible Assets-77.3M-48.6M-166M-198.7M

Cash Flow Statement

Cash Flow Statement history of Dechra Pharmaceuticals PLC (LSE:DPH)

30 Jun 202130 Jun 202030 Jun 201930 Jun 2018
Net Income55.5M33.9M30.9M36.1M
Depreciation40M25.8M21M24.5M
Change To Netincome-20.9M-2.6M-16.2M-10.1M
Change To Account Receivables-19.7M6.9M-11.7M-9.5M
Change To Liabilities20.3M100k6.3M8.6M
Change To Inventory-36.6M-15.7M-14.1M-22.5M
Total Cash From Operating Activities89.1M106.4M81.8M64M
Capital Expenditures-18.9M-7.8M-12M-4.9M
Investments-800k-7.6M-7.6M-7.6M
Total Cashflows From Investing Activities-136.1M-81.5M-61.9M-241.7M
Dividends Paid-37.9M-33.3M-28.4M-21.8M
Net Borrowings-19.5M22.4M7.3M116.2M
Total Cash From Financing Activities-55.1M118.9M-20.1M193.8M
Effect Of Exchange Rate-6.9M3.3M800k2.4M
Change In Cash-109M147.1M600k18.5M
Issuance Of Stock2.3M131.5M1.2M103.3M